Inactive Instrument
Isodiol International Inc. Stock Canadian Securities Exchange
Stocks
ISOL
CA46500L2003
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.82M 2.43M 2.27M 2.08M 269M 3.92M 26.98M 10.53M 136M 10.57M 10.34M 450M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.57M 5.66M 5.31M 4.85M 628M 9.16M 63.01M 24.59M 317M 24.68M 24.14M 1.05B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | +16.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/2017 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 30/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 24/05/2017 |
| Director/Board Member | - | 30/08/2018 | |
| Director/Board Member | - | 21/11/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +16.67% | +40.00% | - | - | 128 | |
| +0.02% | +1.36% | -13.16% | -7.68% | 13.26B | |
| +0.53% | +2.99% | -31.39% | -55.80% | 4.99B | |
| +0.27% | +1.59% | -5.32% | -4.34% | 4.66B | |
| -0.43% | -1.64% | -1.22% | -30.17% | 4.02B | |
| +0.08% | +3.06% | -20.99% | +4.77% | 3.59B | |
| -0.67% | +2.71% | -2.98% | -4.10% | 3.43B | |
| +0.47% | -0.53% | -9.87% | +7.51% | 3.31B | |
| -2.19% | -2.26% | -22.25% | -13.02% | 2.38B | |
| +0.74% | +2.97% | -26.78% | -14.44% | 1.72B | |
| Average | +1.55% | +1.90% | -14.88% | -13.03% | 4.6B | |
| Weighted average by Cap. | -0.05% | +1.73% | -13.98% | -13.29% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.77M 11.87M 11.13M 10.16M 1.32B 19.2M 132M 51.51M 665M 51.71M 50.59M 2.2B | 22.25M 16.01M 13.8M 12.94M 11.81M 1.53B 22.32M 153M 59.89M 773M 60.12M 58.81M 2.56B |
| Net income | -36.02M -25.93M -22.34M -20.95M -19.12M -2.48B -36.14M -249M -96.96M -1.25B -97.34M -95.22M -4.15B | -126M -90.63M -78.09M -73.22M -66.84M -8.66B -126M -869M -339M -4.37B -340M -333M -14.5B |
| Net Debt | -15.55M -11.19M -9.64M -9.04M -8.25M -1.07B -15.6M -107M -41.86M -540M -42.02M -41.11M -1.79B | 5.22M 3.76M 3.24M 3.04M 2.77M 359M 5.24M 36.03M 14.06M 181M 14.11M 13.8M 601M |
Employees
-
Sector
Pharmaceuticals
